4//SEC Filing
BELLICUM PHARMACEUTICALS, INC 4
Accession 0001358403-17-000099
CIK 0001358403operating
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:43 PM ET
Size
5.4 KB
Accession
0001358403-17-000099
Insider Transaction Report
Form 4
Slawin Kevin M.
DirectorCMO and CTO
Transactions
- Award
Stock Option (right to buy)
2017-06-14+10,000→ 10,000 totalExercise: $10.34Exp: 2027-06-13→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest and become exercisable in equal monthly installments until the Issuer's 2018 Annual Meeting of stockholders.
Documents
Issuer
BELLICUM PHARMACEUTICALS, INC
CIK 0001358403
Entity typeoperating
Related Parties
1- filerCIK 0001358403
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:43 PM ET
- Size
- 5.4 KB